Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

References for PMC Articles for PubMed (Select 21609473)

1.

Case management of severe malaria--a forgotten practice: experiences from health facilities in Uganda.

Achan J, Tibenderana J, Kyabayinze D, Mawejje H, Mugizi R, Mpeka B, Talisuna A, D'Alessandro U.

PLoS One. 2011 Mar 1;6(3):e17053. doi: 10.1371/journal.pone.0017053.

2.

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group.

Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7. Erratum in: Lancet. 2011 Jan 8;377(9760):126.

3.

Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.

Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, Snounou G, Ashley EA, McGready R, Nosten F, Guerin PJ.

Lancet Infect Dis. 2010 Nov;10(11):762-9. doi: 10.1016/S1473-3099(10)70202-4.

PMID:
20932805
4.

Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand.

Hüttinger F, Satimai W, Wernsdorfer G, Wiedermann U, Congpuong K, Wernsdorfer WH.

Wien Klin Wochenschr. 2010 Oct;122 Suppl 3:52-6. doi: 10.1007/s00508-010-1438-6.

PMID:
20924699
5.

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.

Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM.

Malar J. 2010 Sep 1;9:249. doi: 10.1186/1475-2875-9-249.

6.

Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration.

Soyinka JO, Onyeji CO, Omoruyi SI, Owolabi AR, Sarma PV, Cook JM.

Br J Clin Pharmacol. 2010 Mar;69(3):262-70. doi: 10.1111/j.1365-2125.2009.03566.x. Erratum in: Br J Clin Pharmacol. 2010 May;69(5):571.

7.

Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon.

Sayang C, Gausseres M, Vernazza-Licht N, Malvy D, Bley D, Millet P.

Malar J. 2009 Jul 29;8:174. doi: 10.1186/1475-2875-8-174.

8.

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.

Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO.

BMJ. 2009 Jul 21;339:b2763. doi: 10.1136/bmj.b2763.

9.

Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?

Yeka A, Achan J, D'Alessandro U, Talisuna AO.

Lancet Infect Dis. 2009 Jul;9(7):448-52. doi: 10.1016/S1473-3099(09)70109-4. Review.

PMID:
19555904
10.

Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.

German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):424-9. doi: 10.1097/QAI.0b013e3181acb4ff.

PMID:
19506482
11.

Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.

Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW.

Am J Trop Med Hyg. 2009 May;80(5):737-8.

12.

Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers.

Soyinka JO, Onyeji CO, Omoruyi SI, Owolabi AR, Sarma PV, Cook JM.

J Pharm Pharmacol. 2009 Apr;61(4):439-43. doi: 10.1211/jpp/61.04.0004.

13.

Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria.

Onwujekwe O, Kaur H, Dike N, Shu E, Uzochukwu B, Hanson K, Okoye V, Okonkwo P.

Malar J. 2009 Feb 10;8:22. doi: 10.1186/1475-2875-8-22.

14.

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.

Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ; Study 13 Research Group.

Lancet. 2009 Feb 14;373(9663):557-66. doi: 10.1016/S0140-6736(08)61734-1. Epub 2008 Dec 6.

15.

[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French.

PMID:
18684691
16.

High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.

Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G.

Clin Infect Dis. 2008 Apr 1;46(7):985-91. doi: 10.1086/529192.

17.

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.

Wasunna B, Zurovac D, Goodman CA, Snow RW.

Malar J. 2008 Feb 5;7:29. doi: 10.1186/1475-2875-7-29.

18.
19.

Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial.

Achan J, Byarugaba J, Barennes H, Tumwine JK.

Clin Infect Dis. 2007 Dec 1;45(11):1446-52. Epub 2007 Oct 22.

20.

In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.

Legrand E, Volney B, Meynard JB, Mercereau-Puijalon O, Esterre P.

Antimicrob Agents Chemother. 2008 Jan;52(1):288-98. Epub 2007 Oct 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk